ICD-10-CM Billable Code

F12.151

Cannabis abuse with psychotic disorder with hallucinations

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F12.151 refers to a condition where cannabis use has led to a psychotic disorder characterized by hallucinations. This condition occurs when an individual using cannabis experiences significant mental health effects that include a distorted perception of reality, such as hearing or seeing things that aren't present. Such symptoms can interfere heavily with daily life and require proper attention and management. Recognizing the symptoms and understanding the causes can help in seeking appropriate treatment and support.

Causes & Symptoms

Clinical Causes: Repeated or heavy cannabis consumption, especially in individuals with a genetic or family history of mental health disorders. Use of cannabis at a young age, when the brain is still developing, increasing vulnerability to psychotic episodes. Pre-existing mental health conditions that may be exacerbated by cannabis use. High potency cannabis products containing elevated levels of THC, the psychoactive component responsible for intoxication and potential psychosis. Environmental stressors or trauma that may increase susceptibility to substance-induced psychosis. Concurrent use of other substances that can increase the risk of psychiatric disturbances.

Key Symptoms: Auditory hallucinations, such as hearing voices or sounds that others do not perceive. Visual hallucinations, seeing objects, people, or scenes that are not present. Delusional thinking or false beliefs that are fixed and unchangeable. Disorganized speech or thought processes. Altered perceptions of reality, including feelings of paranoia or suspicion. Emotional disturbances, such as extreme anxiety, agitation, or confusion. Changes in behavior, including social withdrawal or unusual actions.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive assessment by mental health professionals, including clinical interviews and psychiatric evaluations. Medical history, including cannabis use patterns and family history of mental health issues, is crucial. Sometimes, additional tests, such as blood work or neuroimaging, are used to rule out other causes. The clinician looks for signs of a psychotic episode directly attributable to cannabis use, considering the timing, severity, and persistence of symptoms.

Treatment Protocols: Treatment approaches typically focus on managing symptoms and supporting recovery. These may include: - Psychotherapy, such as cognitive-behavioral therapy (CBT), to help individuals understand and cope with their experiences. - Medication, including antipsychotic drugs, to reduce hallucinations and stabilize mood. - Supportive counseling and psychoeducation for patients and families. - Substance use counseling to address cannabis dependence and prevent future episodes. - Monitoring and follow-up care to track progress and adjust treatments as needed. Early intervention is important to improve outcomes, and managing cannabis use alongside psychiatric treatment is often recommended.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F12.151 a billable ICD-10 code?
Yes, F12.151 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F12.151?
Clinical documentation must specify the nature of Cannabis abuse with psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.

Cite this Clinical Reference